Roger P. A'hern - Publications

Plug or Punctoplasty (POPPY) Study: Perforated Punctal Plug Versus Three-Snip Punctoplasty in the Treatment of Acquired Punctal Stenosis.

Journal: Ophthalmic plastic and reconstructive surgery

Published: March 12, 2026

Prospective randomised controlled trial to compare tissue reactions and scarring with polypropylene versus polyglactin 910 sutures in periocular skin.

Journal: The British journal of ophthalmology

Published: May 09, 2025

'I presumed the pain would eventually get better by itself'; challenges with access to rehabilitation for upper limb dysfunction after breast cancer treatment - Descriptive and qualitative findings from a cross-sectional survey.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: March 20, 2024

Sickle Eye Project: a cross-sectional, non-interventional study of the prevalence of visual impairment due to sickle cell retinopathy and maculopathy in the UK.

Journal: BMJ open

Published: February 28, 2024

Flow Rate and Water Depth Alters Biomass Production and Phytoremediation Capacity of Lemna minor.

Journal: Plants (Basel, Switzerland)

Published: July 19, 2022

Cancer Biology and Survival Analysis in Cancer Trials: Restricted Mean Survival Time Analysis versus Hazard Ratios.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: December 09, 2017

Real-time imaging of single neuronal cell apoptosis in patients with glaucoma.

Journal: Brain : a journal of neurology

Published: November 28, 2016

Restricted Mean Survival Time: An Obligatory End Point for Time-to-Event Analysis in Cancer Trials?

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 11, 2016

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.

Journal: The New England journal of medicine

Published: October 29, 2015

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials).

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: October 16, 2015

A phase II trial to assess the activity of gemcitabine and docetaxel as first line chemotherapy treatment in patients with unresectable leiomyosarcoma.

Journal: Clinical sarcoma research

Published: April 06, 2015

Extreme chromosomal instability forecasts improved outcome in ER-negative breast cancer: a prospective validation cohort study from the TACT trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: February 23, 2015